Elevated Glycosylated Hemoglobin is Associated With Subclinical Neuropathy in Neurologically Asymptomatic Diabetic Patients: A Prospective Study (Q57312183)

From Wikidata

Jump to navigation Jump to search

No description defined

Language	Label	Description	Also known as
English	Elevated Glycosylated Hemoglobin is Associated With Subclinical Neuropathy in Neurologically Asymptomatic Diabetic Patients: A Prospective Study	No description defined

Statements

scholarly article

0 references

Elevated Glycosylated Hemoglobin is Associated With Subclinical Neuropathy in Neurologically Asymptomatic Diabetic Patients: A Prospective Study (English)

0 references

1 reference

based on heuristic

inferred from title

glycated hemoglobin

1 reference

object named as

glycosylated hemoglobin

23 October 2023

based on heuristic

inferred from title

Yousef Saleh Khader

object named as

Yousef Khader

3

0 references

author name string

Khalid El-Salem

1

0 references

Fawaz Ammari

2

0 references

Omar Dhaimat

4

0 references

publication date

February 2009

0 references

Journal of Clinical Neurophysiology

0 references

26

0 references

1

0 references

50-53

0 references

Nerve conduction abnormalities in untreated maturity-onset diabetes: relation to levels of fasting plasma glucose and glycosylated hemoglobin

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.7326/0003-4819-90-3-298

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

The diabetic neuropathies

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

A comparison of electrophysiological tests for the early diagnosis of diabetic neuropathy

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Sural/radial amplitude ratio in the diagnosis of mild axonal polyneuropathy

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Diabetic neuropathy: Influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Subclinical nerve dysfunction in children and adolescents with IDDM

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Nerve function and metabolic control in teenage diabetics

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Diabetic neuropathy

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Standards of medical care in diabetes

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Subclinical neuropathy in type I diabetic children.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/WNP.0B013E31819862EE

Identifiers

10.1097/WNP.0B013E31819862EE

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57312183&oldid=1996127809"